Moderna bags another US CDMO to help with fill-finish work for its vaccine amid booster push
Moderna has enlisted another CDMO to ramp up Covid-19 vaccine manufacturing capability in its effort to provide 3 billion doses in 2022.
Starting in Q3, Thermo Fisher Scientific will carry out fill-finish, labeling and packaging services to support Moderna at the CDMO’s Greenville, NC site, the company said in a release.
“Thermo Fisher has been a critical partner in supplying raw materials for our COVID-19 vaccine and we are now pleased to further expand our relationship as an important manufacturing partner as well,” said Juan Andres, Moderna’s chief technical operations and quality officer, in a statement. “The addition of Thermo Fisher to our network will support our efforts to scale up our manufacturing ability.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.